Xenon Pharmaceuticals Inc. SEC filings XENE
Xenon Pharmaceuticals Inc. has 800 filings in SEC EDGAR's recent list, going back to Aug 16, 2013. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 4 | Insider transaction | Oct 16, 2026 | Oct 15, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 31, 2026 | Aug 28, 2026 |
| 144 | Notice of proposed sale | Aug 28, 2026 | — |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 144 | Notice of proposed sale | Jun 5, 2026 | — |
| 144 | Notice of proposed sale | Jun 5, 2026 | — |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 | Employee stock plan registration | Jun 3, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | Jun 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 4 | Insider transaction | May 13, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Apr 22, 2026 |
| S-8 | Employee stock plan registration | Apr 13, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 12, 2026 |
| 144 | Notice of proposed sale | Mar 13, 2026 | — |
| 144 | Notice of proposed sale | Mar 13, 2026 | — |
| 144 | Notice of proposed sale | Mar 13, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 13, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 12, 2026 | Mar 10, 2026 |
| 424B5 | Prospectus supplement | Mar 12, 2026 | — |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| FWP | Free writing prospectus | Mar 11, 2026 | — |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| 424B5 | Prospectus supplement | Mar 9, 2026 | — |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Other events
|
Feb 27, 2026 | Feb 27, 2026 |
| 424B5 | Prospectus supplement | Feb 27, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2026 | — |
| 4 | Insider transaction | Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 2, 2026 | Jan 2, 2026 |
| 144 | Notice of proposed sale | Jan 2, 2026 | — |
| 4 | Insider transaction | Dec 9, 2025 | Dec 5, 2025 |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 5, 2025 | — |
| 4 | Insider transaction | Dec 3, 2025 | Nov 28, 2025 |
| 144 | Notice of proposed sale | Dec 1, 2025 | — |
| S-8 | Employee stock plan registration | Dec 1, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2025 | Nov 24, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 3 | Initial insider ownership | Oct 17, 2025 | Oct 15, 2025 |
| 8-K/A |
Amended current report
Officer or director change, Other events
|
Oct 17, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 1, 2025 | Oct 1, 2025 |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 144 | Notice of proposed sale | Sep 19, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 23, 2025 |
| 3 | Initial insider ownership | Jun 24, 2025 | Jun 23, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Apr 24, 2025 |
| 8-K |
Current report
Other events
|
Mar 17, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 12, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 12, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 7, 2025 | — |
| 8-K |
Current report
Auditor change
|
Mar 5, 2025 | Mar 3, 2025 |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Feb 27, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Jan 27, 2025 | Jan 23, 2025 |
| 144 | Notice of proposed sale | Jan 27, 2025 | — |
| 144 | Notice of proposed sale | Jan 24, 2025 | — |
| 144 | Notice of proposed sale | Jan 23, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 17, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Dec 19, 2024 | Dec 18, 2024 |
| 144 | Notice of proposed sale | Dec 18, 2024 | — |
| 4 | Insider transaction | Nov 22, 2024 | Nov 22, 2024 |
| 144 | Notice of proposed sale | Nov 22, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| S-3ASR | Automatic shelf registration | Aug 9, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 144 | Notice of proposed sale | Jul 12, 2024 | — |
| 144 | Notice of proposed sale | Jun 12, 2024 | — |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 144 | Notice of proposed sale | Jun 5, 2024 | — |
| S-8 | Employee stock plan registration | Jun 5, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2024 | Apr 15, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 11, 2024 | Mar 8, 2024 |
| 144 | Notice of proposed sale | Mar 8, 2024 | — |
| 4 | Insider transaction | Mar 8, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Other events
|
Mar 8, 2024 | Mar 8, 2024 |
| 144 | Notice of proposed sale | Mar 7, 2024 | — |
| 144 | Notice of proposed sale | Mar 7, 2024 | — |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 29, 2024 | Feb 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2024 | — |
| 4 | Insider transaction | Jan 2, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Dec 20, 2023 | Dec 19, 2023 |
| 4/A | Filing | Dec 15, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 144 | Notice of proposed sale | Dec 14, 2023 | — |
| 144 | Notice of proposed sale | Dec 13, 2023 | — |
| 424B5 | Prospectus supplement | Nov 30, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 30, 2023 | Nov 29, 2023 |
| 424B5 | Prospectus supplement | Nov 29, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 27, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2023 | Nov 8, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 24, 2023 |
| 144 | Notice of proposed sale | Aug 24, 2023 | — |
| 4 | Insider transaction | Aug 10, 2023 | Aug 10, 2023 |
| 3 | Initial insider ownership | Aug 10, 2023 | Aug 8, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 10, 2023 |
| 3 | Initial insider ownership | Aug 10, 2023 | Aug 8, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 8, 2023 | Aug 8, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XENE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Burnaby
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1582313
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.